ElizabethMBlanchardMD

Hematologic Oncology, Thoracic Cancer

Director, Cancer Clinical Trials

Dr. Blanchard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
206 Mill Rd
Fairhaven, MA 02719
Phone+1 508-973-3000

Fax+1 508-973-3119

Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
Boston University Medical CenterResidency, Internal Medicine, 1999 - 2002
Saint Louis University School of MedicineClass of 1999

PubMed

6 citations
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez
Journal of Clinical Oncology. 2024-04-10
9 citations
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez
Journal of Clinical Oncology. 2024-04-10
6 citations
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3.
Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano
Journal of Clinical Oncology. 2023-04-10

ASCO Announces 2020 AwardsApril 24th, 2020
Doctors Welcome CDC’s Clarification of Opioid Prescribing, as Guideline Authors Say It Was MisappliedApril 25th, 2019
New Infographic, Commentaries Highlight Role of Opioids in Managing Cancer-Related PainApril 23rd, 2019
Join now to see all